By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Critical Pharmaceuticals Limited 

BioCity Nottingham
Pennyfoot Street
Nottingham    NG1 1GF  United Kingdom
Phone: 44-115-9124371 Fax: 44-115-9124371



Company News
Critical Pharmaceuticals Limited, The University of Nottingham And Nottingham University Hospitals NHS Trust Starts First Phase I Clinical Trial On A Nano-Enabled Intranasal Teriparatide For The Treatment Of Osteoporosis 4/15/2014 11:16:35 AM
Critical Pharmaceuticals Limited Receives Notice Of Allowance From US Patent And Trademark Office For Intranasal Growth Hormone And Parathyroid Hormone Products 4/8/2014 1:24:57 PM
Critical Pharmaceuticals Limited Announces Successful Completion of Second Clinical Trial on CP024 Intranasal Growth Hormone 2/12/2013 11:00:34 AM
Critical Pharmaceuticals Limited and the University of Nottingham to Develop Nano-Enabled Nasal Spray for Osteoporosis 2/16/2012 9:07:17 AM
Critical Pharmaceuticals Limited Announce Interim Results of CP024 Nasal hGH Phase 1 Program that Show Comparable Bioactivity to Injection 9/6/2011 11:28:34 AM
PolyTherics and Critical Pharmaceuticals Limited Enter Drug Development Collaboration with Funding From the Technology Strategy Board 4/5/2011 8:53:23 AM
Critical Pharmaceuticals Limited CriticalSorb(TM) Nasal Drug Delivery Technology Shows Excellent Local Tolerability in Long Term Preclinical Studies 3/8/2011 10:10:56 AM
Critical Pharmaceuticals Limited Secures £1.5M from Wellcome Trust to Develop hGH Nasal Spray 10/14/2009 9:53:23 AM
Global Health Ventures and Critical Pharmaceuticals Limited Sign Memorandum of Understanding for Anti-Obesity Drug 1/28/2009 10:45:25 AM
Critical Pharmaceuticals Limited Raise GBP650K Investors Endorse CriticalMix Drug Delivery Technology and own Pipeline Potential 11/10/2008 9:10:08 AM